et_marketsabout 2 hours ago
NEUTRAL(85%)
hold
Nifty at crossroads: Somil Mehta on why 23,000 is the line that cannot break
Read original source+40.4
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The Pharma sector is currently seeing analyst interest for 2026, with several reports highlighting top stocks. However, it has also faced headwinds from US curbs in the past.
Trading Insight
Consider long positions in fundamentally strong Pharma stocks on dips, watching for positive regulatory news and product pipeline developments.
Quick check: NIFTY neutral, SUNPHARMA bearish bias (-1.8% 1d).
Key Evidence
- •Nifty 50 is poised for a short-term bounce from the 23,000 level.
- •Technical analysts anticipate a recovery towards 23,500-23,600.
- •The broader trend signals caution, with a medium-term target of 22,750.
- •Investors should focus on Power, Pharma, and IT sectors for potential opportunities.
- •The upcoming truncated week may see increased volatility.
People in this Story
S
AI-powered analysis by
Anadi Algo News